Histone Serotonylation Promotes Pancreatic Cancer Development via Lipid Metabolism Remodeling

Researchers observed the higher levels of histone serotonylation and transglutaminases 2 in both PDAC tissues and cell lines in comparison with their normal counterparts, and inhibition of histone serotonylation suppresses PDAC development.